HY
Humera Yaseen
About Humera Yaseen
Data last updated:
Humera Yaseen is a Director at Orange Medipharmaceuticals Private Limited (since 2015). The companies operate in Pharma. Orange Medipharmaceuticals Private Limited reported revenue of ₹74.4 Lakh (FY 2024). Earlier, Humera Yaseen was a Designated Partner at Orange Medipharma Llp (from 2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Orange Medipharmaceuticals Private Limited U24233UP2015PTC074326 | Director | 05 Nov 2015 | 2015 | ₹74.4 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Orange Medipharma Llp AAD-7787 | Designated Partner | 17 Apr 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Humera Yaseen
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abdullah Saleh Salmen Anooz Al Ameri | 07768053 | Orange Medipharmaceuticals Private Limited | Director |
| Imran Ahmad Ansari | 07155732 | Orange Medipharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Humera Yaseen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Humera Yaseen
Humera Yaseen currently holds 1 directorship: Orange Medipharmaceuticals Private Limited (Director, since 05 Nov 2015, revenue ₹74.4 Lakh (FY 2024)).
Humera Yaseen was first appointed on 17 Apr 2015 as Designated Partner at Orange Medipharma Llp.
Humera Yaseen held 1 earlier board appointment: Orange Medipharma Llp (Designated Partner, from 17 Apr 2015).
The current boards of Humera Yaseen's companies include Abdullah Saleh Salmen Anooz Al Ameri (Orange Medipharmaceuticals Private Limited), Imran Ahmad Ansari (Orange Medipharmaceuticals Private Limited).